Streetbeat News

Stock Prices

IMGN

Immunogen (NASDAQ:IMGN) is set to release its latest quarterly earnings report on Monday, 2023-07-31. Analysts estimate an earnings per share (EPS) of $-0.14. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $18.46 and has seen a 327.7% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

July 28, 2023 | 6:02 pm

RMBS

Rambus (NASDAQ:RMBS) is set to release its quarterly earnings report on Monday, 2023-07-31. Analysts estimate an earnings per share (EPS) of $0.40. Last quarter, the company missed EPS by $0.39, which was followed by a 7.13% increase in the share price. Shares of Rambus were trading at $60.97 as of July 27, with a 147.47% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

July 28, 2023 | 6:02 pm

SANM

Sanmina (NASDAQ:SANM) is set to release its latest quarterly earnings report on July 31, 2023. Analysts estimate an earnings per share (EPS) of $1.53. The company's past performance shows a pattern of beating EPS estimates, but this has not always led to a rise in share price. Shares of Sanmina were trading at $59.88 as of July 27, with a 30.93% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

July 28, 2023 | 6:02 pm

CGAU

Centerra Gold (NYSE:CGAU) is set to release its quarterly earnings report on July 31, 2023. Analysts estimate an earnings per share (EPS) of $-0.20. The company's past performance shows a pattern of EPS misses followed by share price increases. The stock is currently trading at $5.97, down 0.81% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

July 28, 2023 | 6:02 pm

CAMT

Camtek (NASDAQ:CAMT) is set to release its latest quarterly earnings report on July 31, 2023. Analysts estimate an earnings per share (EPS) of $0.42. The company's past performance shows a trend of beating EPS estimates but experiencing a slight drop in share price the following day. Shares of Camtek were trading at $46.0 as of July 27, with a 52-week increase of 61.6%.

Portfolio Pulse from Benzinga Insights

July 28, 2023 | 6:01 pm

KIDS

OrthoPediatrics (NASDAQ:KIDS) is set to release its latest quarterly earnings report on July 31, 2023. Analysts estimate an earnings per share (EPS) of $-0.22. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $41.3, down 11.4% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

July 28, 2023 | 6:01 pm

ATVI

A significant amount of unusual options activity has been observed for Activision Blizzard (NASDAQ:ATVI), with a majority of investors taking a bullish stance. The trades include 2 puts amounting to $90,000 and 11 calls amounting to $1,474,802. Whales have been targeting a price range from $77.5 to $95.0 for Activision Blizzard over the last 3 months. Deutsche Bank maintains a Buy rating on Activision Blizzard with a price target of $95, while Citigroup, Truist Securities, and MoffettNathanson have downgraded their actions to Hold with a price target of $95. Benchmark has downgraded its action to Hold with a price target of $90.

Portfolio Pulse from Benzinga Insights

July 28, 2023 | 6:01 pm

MU

A significant bearish stance has been taken on Micron Technology (NASDAQ:MU) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is split between 40% bullish and 60% bearish. The whales have been targeting a price range from $45.0 to $90.0 for Micron Technology over the last 3 months. The current price of MU is down -0.4% at $70.78. Several financial institutions have maintained their ratings on Micron Technology with price targets ranging from $75 to $80.

Portfolio Pulse from Benzinga Insights

July 28, 2023 | 6:01 pm

CNX

Analysts have provided indifferent to somewhat bearish ratings for CNX Resources (NYSE:CNX) in the last quarter. According to 4 analysts offering 12-month price targets in the last 3 months, CNX Resources has an average price target of $17.5, which has increased by 4.48% over the past month.

Portfolio Pulse from Benzinga Insights

July 28, 2023 | 6:01 pm

EOLS

Evolus (NASDAQ:EOLS) has received five bullish analyst ratings in the last quarter, with an average 12-month price target of $18.4, up 15.0% from the previous average price target of $16.00. No bearish or indifferent ratings were observed.

Portfolio Pulse from Benzinga Insights

July 28, 2023 | 6:01 pm